Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
8.24
+0.11 (1.35%)
At close: Nov 20, 2024, 4:00 PM
8.25
+0.01 (0.12%)
Pre-market: Nov 21, 2024, 4:32 AM EST

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1,1801,2916142,9661,7502,210
Upgrade
Market Cap Growth
-5.95%110.30%-79.30%69.42%-20.79%279.54%
Upgrade
Enterprise Value
9191,0472462,6881,3672,076
Upgrade
Last Close Price
8.248.994.3222.8713.8320.26
Upgrade
PS Ratio
5.367.364.5865.0334.936948.95
Upgrade
PB Ratio
3.043.421.516.194.297.40
Upgrade
P/TBV Ratio
2.733.461.546.304.397.63
Upgrade
EV/Sales Ratio
4.175.971.8458.9427.276527.06
Upgrade
Debt / Equity Ratio
0.230.260.020.020.02-
Upgrade
Asset Turnover
0.400.340.260.090.130.00
Upgrade
Inventory Turnover
1.431.982.303.14--
Upgrade
Quick Ratio
4.894.868.7611.8412.4527.13
Upgrade
Current Ratio
5.605.509.6012.6313.1127.90
Upgrade
Return on Equity (ROE)
-5.78%-19.92%-24.46%-40.81%-29.07%-42.99%
Upgrade
Return on Assets (ROA)
-2.15%-10.52%-13.74%-22.43%-16.54%-24.18%
Upgrade
Return on Capital (ROIC)
-2.48%-12.06%-15.46%-24.99%-18.24%-27.65%
Upgrade
Earnings Yield
-1.91%-6.04%-17.62%-6.10%-5.87%-4.00%
Upgrade
FCF Yield
2.40%-2.65%-13.00%-5.33%-4.31%-2.88%
Upgrade
Buyback Yield / Dilution
-0.41%-0.93%-9.70%-9.20%-27.36%-9.72%
Upgrade
Total Shareholder Return
-0.41%-0.93%-9.70%-9.20%-27.36%-9.72%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.